Cardiology research

Dynamic heart model gives insight into cardiac disease progression

Efforts to understand cardiac disease progression and develop therapeutic tissues that can repair the human heart are just a few areas of focus for the Feinberg research group at Carnegie Mellon University.

model of human heart anatomy
Heart anatomy model (symbolic photo)

Image source: Unsplash/jesse orrico

The group's latest dynamic model, created in partnership with collaborators in the Netherlands, mimics physiologic loads on engineering heart muscle tissues, yielding an unprecedented view of how genetics and mechanical forces contribute to heart muscle function. "Our lab has been working for a long time on engineering and building human heart muscle tissue, so we can better track how disease manifests and also, create therapeutic tissues to one day repair and replace heart damage," explains Adam Feinberg, a professor of biomedical engineering and materials science and engineering. "One of the challenges is that we have to build these small pieces of heart muscle in a petri dish, and we've been doing that for many years. What we've realized is that these in-vitro systems do not accurately recreate the mechanical loading we see in the real heart due to blood pressure."

Hemodynamic loads, or the preload (stretch on heart muscle during chamber filling) and afterload (when the heart muscle contracts), are important not only for healthy heart muscle function, but can also contribute to cardiac disease progression. Preload and afterload can lead to maladaptive changes in heart muscle, as is the case of hypertension, myocardial infarction, and cardiomyopathies.

In new research published in Science Translational Medicine, the group introduces a system comprised of engineered heart muscle tissue (EHT) that is attached to an elastic strip designed to mimic physiologic preloads and afterloads. This first-of-its-kind model shows that recreating exercise-like loading drives formation of more functional heart muscle that is better organized and generates more force each time it contracts. However, using cells from patients with certain types of heart disease, these same exercise-like loads can result in heart muscle dysfunction.

"One of the really important things about this work is that it's a collaborative effort between our lab and collaborators in the Netherlands, including Cardiologist Peter van der Meer," says Feinberg. "Peter treats patients that have genetically-linked cardiovascular disease, including a type called arrhythmogenic cardiomyopathy (ACM) that often becomes worse with exercise. We have been able to get patient-specific induced pluripotent stem cells, differentiate these into heart muscle cells, and then use these in our new EHT model to recreate ACM in a petri dish, so we can better understand it." Jacqueline Bliley, a biomedical engineering graduate student and co-first author of the recently published paper, adds, "The collaborative nature of this work is so important, to be able to ensure reproducibility of the research and compare findings across the world."

Looking to the future, the collaborators aim to use their model and findings to study a wide range of other heart diseases with genetic mutations, develop new therapeutic treatments and test drugs to gauge their effectiveness. "We can take lessons learned from building the EHT in a dish to create larger pieces of heart muscle that could be used therapeutically. By combining these new results with our previous work involving 3D bioprinting heart muscle, we hope to one day engineer tissues large and functional enough to implant, and repair the human heart," projects Feinberg.


Source: Carnegie Mellon University

23.07.2021

Read all latest stories

Related articles

Photo

Gender bias

Sex-specific guidelines for cardiovascular diseases

Women are missing out on appropriate cardiac care because guidelines and medications often fail to take into account gender and conditions that specifically affect the female population. Women are…

Photo

Disease of smallest heart blood vessels

Microvascular angina: the global health problem you've never heard of

For the first time, a prospective, international study has shown that chest pain caused by problems with the very small vessels supplying blood to the heart is an important health problem that…

Photo

Heartbeat in a dish

"Cardioids" hold great promise for heart disease research

Self-organizing heart organoids – developed at the Austrian Academy of Sciences – are also effective injury- and in vitro congenital disease models. These “cardioids” may revolutionize…

Related products

Alsachim, a Shimadzu group company – Dosinaco

Clinical Chemistry

Alsachim, a Shimadzu group company – Dosinaco

Alsachim, a Shimadzu Group Company
Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
SIUI · Apogee 6500 Color Doppler Ultrasound Imaging System

Artificial Intelligence

SIUI · Apogee 6500 Color Doppler Ultrasound Imaging System

Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
Subscribe to Newsletter